Health-care companies rose, recouping some of their recent losses. Shares of UnitedHealth Group, CVS Health and Cigna moved into the green for 2025 after a punishing fourth quarter.
Bayer's projected earnings decline and litigation pressures affect its outlook. Find out why BAYRY stock might face ...
The largest verdicts were against Monsanto, Exxon Mobil, OCF Construction and other contractors, and Temple University.
It's one of many changes Bayer CEO Bill Anderson has made. Still, the company's stock price this year has struggled.
The coming year will see a continuation of some long-running mass tort litigation based on traditional product liability ...
Bayer’s market cap has fallen more than 44% this year. The group’s $63 billion acquisition of Roundup weed killer parent Monsanto in 2018 has proved disastrous for Bayer, as it faced wave ...